Dermatology
Review | Monkeypox.
27 Oct, 2022 | 12:36h | UTCMonkeypox – New England Journal of Medicine
Related:
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
Commentary on Twitter
Monkeypox cases reported in the United Kingdom, Portugal, and Italy in May 2022 led the WHO to declare a global health emergency. The authors review the virology, epidemiology, clinical features, and treatment of monkeypox. https://t.co/dk2ZxxPsN7 pic.twitter.com/u3gzD6V7Bo
— NEJM (@NEJM) October 26, 2022
Two Phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo.
21 Oct, 2022 | 13:03h | UTCTwo Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Ruxolitinib Cream Results in Greater Repigmentation in Vitiligo – HealthDay
Cohort Study | Use of straighteners and other hair products and incident uterine cancer.
20 Oct, 2022 | 12:28h | UTCNews Release: Hair straightening chemicals associated with higher uterine cancer risk – NIH News Releases
Commentaries:
Hair-straightening chemical products linked to increased uterine cancer risk in new study – CNN
Hair straightening chemicals may increase women’s risk of uterine cancer, study finds – NPR
Safety of Upadacitinib in moderate-to-severe atopic dermatitis: an integrated analysis of phase 3 studies.
19 Oct, 2022 | 14:14h | UTC
M-A | Incidence of cutaneous adverse events with Phosphoinositide 3-Kinase inhibitors as adjuvant therapy in patients with cancer.
14 Oct, 2022 | 14:01h | UTCIncidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer: A Systematic Review and Meta-analysis – JAMA Oncology (free for a limited period)
M-A | Complications of hidradenitis suppurativa after surgical management.
13 Oct, 2022 | 13:40h | UTCCommentary: Assessing Surgical Complications in Management of Hidradenitis Suppurativa – AJMC
RCT | Intravenous immune globulin reduces disease activity in dermatomyositis.
6 Oct, 2022 | 13:48h | UTCTrial of Intravenous Immune Globulin in Dermatomyositis – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
NEJM: trial of IVIG for autoimmune disorder dermatomyositis – MedicalResearch.com
IV Immune Globulin Bests Placebo for Dermatomyositis – Drugs.com
M-A | Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis.
6 Oct, 2022 | 13:37h | UTC
WAO/EAACI guideline for the management of hereditary angioedema.
4 Oct, 2022 | 14:34h | UTC
AAP Clinical Report | Controlling and treating head lice in children and adolescents.
3 Oct, 2022 | 14:04h | UTC
Systematic Review | Laser therapy for treating hypertrophic and keloid scars – not enough evidence to guide recommendations.
30 Sep, 2022 | 12:27h | UTCLaser therapy for treating hypertrophic and keloid scars – Cochrane Library
Summary: Laser therapy for hypertrophic and keloid scars – Cochrane Library
RCT | Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants.
28 Sep, 2022 | 13:35h | UTCCommentary: Early Use of Short-term Emollients Linked With Reduced Incidence of AD in High-risk Infants – AJMC
Commentary on Twitter
Can early barrier targeted interventions prevent development of #atopicdermatitis ?
Here’s our contribution.
After negative signals in BEEP and PreventADALL. We suggest earlier intervention with specific emollients may have a role.
More work neededhttps://t.co/GDscCeD1LS pic.twitter.com/ZqEqHMyhcW
— Alan Irvine (@irvinederm) August 27, 2022
Diagnosis and management of Monkeypox: a review for the emergency clinician.
26 Sep, 2022 | 12:07h | UTCRelated:
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
RCTs | Effect of Roflumilast cream vs. vehicle cream on chronic plaque psoriasis.
22 Sep, 2022 | 13:06h | UTCEffect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials – JAMA (free for a limited period)
Editorial: Roflumilast for Chronic Plaque Psoriasis – JAMA
Commentary: Study Suggests Roflumilast May Be Effective As Treatment For Plaque Psoriasis – HCPLive
Commentary on Twitter
Roflumilast cream resulted in better chronic plaque psoriasis clinical status compared with vehicle cream at 8 weeks; further research is needed to compare efficacy with other active treatments and to assess longer-term efficacy and safety. https://t.co/DyGNNjr5ea #Research pic.twitter.com/QnMcChnht6
— JAMA (@JAMA_current) September 21, 2022
RCT | Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis.
20 Sep, 2022 | 13:20h | UTCCommentary: Dupilumab Eases Atopic Dermatitis in Children Younger Than 6 Years – HealthDay
RCT | Deucravacitinib vs. placebo and Apremilast in moderate to severe plaque psoriasis.
20 Sep, 2022 | 13:16h | UTC
RCT | Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis/cruris.
15 Sep, 2022 | 13:10h | UTCEffect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial – JAMA Dermatology (free for a limited period)
Commentary on Twitter
Itraconazole is highly efficacious at all 3 doses but requires prolonged treatment, and a substantial number of patients relapsed after successful treatment. https://t.co/oOMkvp1WIp #Research pic.twitter.com/PoNYu50Cxr
— JAMA Dermatology (@JAMADerm) September 14, 2022
Monkeypox: disease epidemiology, host immunity and clinical interventions.
11 Sep, 2022 | 22:54h | UTC
Commentary on Twitter
Monkeypox: disease epidemiology, host immunity and clinical interventions https://t.co/dmu06NZoPt pic.twitter.com/vZqbxp7Wzn
— Nature Rev Immunol (@NatRevImmunol) September 8, 2022
European guideline (EuroGuiDerm) on atopic eczema – Part II | Non-systemic treatments and treatment recommendations for special AE patient populations.
5 Sep, 2022 | 14:32h | UTC
Reports of asymptomatic monkeypox suggest that, at the very least, some infections go unnoticed.
1 Sep, 2022 | 11:54h | UTC
RCT | Optical coherence tomography vs. punch biopsy for diagnosis of basal cell carcinoma.
31 Aug, 2022 | 11:31h | UTCOptical coherence tomography versus punch biopsy for diagnosis of basal cell carcinoma: a multicentre, randomised, non-inferiority trial – The Lancet Oncology (link to abstract – $ for full-text)
Monkeypox: a clinical update for pediatricians.
24 Aug, 2022 | 14:19h | UTCMonkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
Related:
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
M-A of randomized trials | Risk of cutaneous adverse events in cancer patients treated with phosphatidylinositol-3-kinase inhibitors.
24 Aug, 2022 | 14:12h | UTC
Clinical practice guidelines for the management of atopic dermatitis.
24 Aug, 2022 | 14:13h | UTC
European guideline on atopic eczema – Part I: systemic therapy.
19 Aug, 2022 | 16:14h | UTC